Stearylsulfamide

Stearylsulfamide

SCHEMBL5731325

CCCCCCC.CCCCCCCCCCCCCCCCCC(=O)NS(=O)(=O)c1ccc(N)cc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.58
TSHR P16473 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
DHFR P00374 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
EPHX2 P34913 1/20 0.55
CA1 P00915 3/20 0.52
CA2 P00918 3/20 0.52
MAPT P10636 1/20 0.52
CA12 O43570 2/20 0.50
CA9 Q16790 2/20 0.50
RAB9A P51151 2/20 0.49
KMT2A Q03164 2/20 0.49
FBP1 P09467 1/20 0.47
LMNA P02545 2/20 0.47
MEN1 O00255 1/20 0.47
ALB P02768 1/20 0.46
CYP2C9 P11712 1/20 0.46
AKT1 P31749 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL107968 1.00 ALDH1A1 (0.58) ALDH1A1TSHRTDP1DHFRSMN1; SMN2
Stearylsulfamide SCHEMBL17981340 1.00 ALDH1A1 (0.58) ALDH1A1TSHRTDP1DHFRSMN1; SMN2
Stearylsulfamide SCHEMBL15335 1.00 ALDH1A1 (0.58) ALDH1A1TSHRTDP1DHFRSMN1; SMN2
Stearylsulfamide SCHEMBL2714792 0.99 ALDH1A1 (0.57) ALDH1A1TSHRTDP1DHFRSMN1; SMN2
Stearylsulfamide SCHEMBL4663113 0.99 ALDH1A1 (0.57) ALDH1A1TSHRTDP1DHFRSMN1; SMN2
Stearylsulfamide SCHEMBL1392023 0.99 ALDH1A1 (0.57) ALDH1A1TSHRTDP1DHFRSMN1; SMN2
Stearylsulfamide SCHEMBL9070453 0.99 ALDH1A1 (0.57) ALDH1A1TSHRTDP1DHFRSMN1; SMN2
Stearylsulfamide SCHEMBL322075 0.99 ALDH1A1 (0.57) ALDH1A1TSHRTDP1DHFRSMN1; SMN2
Stearylsulfamide SCHEMBL2367792 0.99 ALDH1A1 (0.57) ALDH1A1TSHRTDP1DHFRSMN1; SMN2
Stearylsulfamide SCHEMBL7583057 0.99 ALDH1A1 (0.57) ALDH1A1TSHRTDP1DHFRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1624897-A2 HIV PRODRUGS CLEAVABLE BY CD26 Tibotec Pharmaceuticals Ltd. (IE) 2006-02-15 EP disclosed
WO-2004099135-A2 HIV PRODRUGS CLEAVABLE BY CD26 TIBOTEC PHARMACEUTICALS LTD. (IE) 2004-11-18 WO disclosed